Search the Newsreel

Senior VP Clement sells $570,200 of Vulcan Materials (VMC) stock

David P. Clement, Senior Vice President at Vulcan Materials Co., sold 2,000 shares of company stock for $570,200 on August 7, 2026. Following this transaction, Clement directly holds 6,716 shares and an additional 1,277.5 shares through a 401(k) plan. The company recently reported strong …

VP sênior Clement vende US$ 570.200 em ações da Vulcan Materials (VMC) - Investing.com Brasil

Stronger Q2 Results And Higher 2026 Output Guidance Could Be A Game Changer For Cenovus Energy (TSX:CVE)

Cenovus Energy reported strong Q2 2026 results with increased sales and net income, along with higher upstream production and an upgraded 2026 production guidance. The company also continues a share buyback program and maintains its quarterly dividend. These developments reinforce Cenovus's short-term volume and …

Is Vulcan Energy (ASX:VUL) Quietly Recasting Its Board For Deeper Mining Credibility And ESG Scrutiny?

Insider Selling: Vulcan Materials (NYSE:VMC) SVP Sells 2,000 Shares of Stock

Vulcan Materials (NYSE:VMC) SVP David Clement sold 2,000 shares of the company's stock for $570,200, reducing his direct ownership by 22.95%. The company recently reported strong quarterly earnings, beating analyst estimates, and declared a quarterly dividend of $0.52 per share. Analysts currently have a …

ENvue Medical (FEED) seeks up to $50M via shelf for stock, warrants, units

ENvue Medical (FEED) has filed a shelf registration to offer up to $50 million in common stock, warrants, and units, which may be sold over time. The company's common stock trades on Nasdaq under the symbol FEED, with a recent price of $0.40 per …

Kenvue Inc (KVUE) Stock News Today

This article provides Kenvue Inc (KVUE) stock news, including its current stock price, market capitalization, and P/E ratio. It highlights the company's recent Q2 2026 earnings report, which showed increased sales and EPS despite narrowing margins. The page also offers various financial data, analyst …

Vulcan Materials Insider Sold Shares Worth $570,200, According to a Recent SEC Filing

An insider at Vulcan Materials (VMC) recently sold shares valued at $570,200, as reported in a new SEC filing. The company specializes in construction materials like aggregates, asphalt, and concrete, with the majority of its sales in the United States. This news follows several …

Vulcan Materials (VMC) SVP David Clement sells 2,000 shares at $285.10

David P. Clement, Senior Vice President of Vulcan Materials (VMC), reported selling 2,000 shares of common stock at $285.10 per share on August 7, 2026. Following this transaction, he directly holds 6,716 common shares and an additional 1,277.5 shares through a 401(k) plan. This …

Kenvue Inc. Stock 12‑Month Price Target Cut to $19.4, Implies 1% Upside

Kenvue Inc.'s average 12-month price target has been lowered from $19.5 to $19.4 by 10 analysts, with forecasts ranging from $18 to $22 per share. This updated target suggests a 1% potential upside from its August 7 closing price. The consensus rating for Kenvue …

Cenovus Energy (NYSE:CVE) Rides High Growth Momentum with a Breakout Setup

HSBC Adjusts Price Target on Kenvue to $19 From $20, Maintains Hold Rating

HSBC has revised its price target for Kenvue (KVUE) to $19, down from the previous $20, while reaffirming a Hold rating on the stock. This adjustment comes amidst recent news including Kenvue's Q2 adjusted earnings and revenue rising, as well as the company missing …

Vulcan Materials Company $VMC Stake Boosted by NewEdge Advisors LLC

Is Corvus Pharmaceuticals (CRVS) Undervalued After A Wider Q2 Loss?

Corvus Pharmaceuticals (CRVS) reported a wider Q2 2026 net loss, leading to a recent share price pullback despite strong longer-term momentum. Analysts have a consensus price target of $35, suggesting the stock is undervalued based on future earnings and growth assumptions, though its current …

Cenovus Energy Inc (CVE) Earnings Forecast: Future EPS & Revenue Growth Estimates

Kenvue Q2: Skin Health & Beauty Net Sales Rise 5.1%

Kenvue reported strong Q2 2026 results with overall net sales up 3.0% and organic sales up 1.6%. The Skin Health & Beauty segment was a key driver, seeing a 5.1% increase in net sales, attributed to strong e-commerce performance, strategic execution, and innovations. The …

Vulcan Materials (VMC) vs. MLM and EXP: Can Its Aggregates Shift Keep Lifting Margins?

Is VMC a good stock to buy? We came across a bullish thesis on Vulcan Materials Company on Contrarian Indicator's Substack by Cameron Fen. In this article, we will summarize the bulls' thesis on VMC. Vulcan Materials Company's share was trading at $281.63 as …

(CVE) Volatility Zones as Tactical Triggers

This article analyzes Cenovus Energy Inc (NYSE: CVE) using AI models to identify volatility zones and tactical triggers for trading. It highlights a weak near-term sentiment challenging long-term strength, an exceptional short setup, and divergent sentiment across different time horizons. The analysis provides specific …

Why You Might Be Interested In Vulcan Materials Company (NYSE:VMC) For Its Upcoming Dividend

Vulcan Materials Company (NYSE:VMC) is set to trade ex-dividend soon, offering a payment of US$0.52 per share. The company demonstrates strong financial health with a low payout ratio of 24% of income and 26% of free cash flow, suggesting dividend sustainability. Vulcan Materials has …

Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Receives Average Recommendation of "Moderate Buy" from Analysts

Corvus Pharmaceuticals (NASDAQ:CRVS) has received a "Moderate Buy" average recommendation from eight research firms, with an average 12-month price target of $33.33, significantly higher than its current share price of $13.92. Despite a recent quarterly loss that missed analyst expectations, institutional ownership is strong, …

Jacobs & Co. CA Has $1.83 Million Stake in Kenvue Inc. $KVUE

Jacobs & Co. CA significantly reduced its stake in Kenvue Inc. by 45.7% in the second quarter, now holding 96,044 shares valued at $1.83 million. Despite missing analyst expectations for Q2 adjusted EPS and revenue, Kenvue's revenue increased by 3.0% year over year, and …

Assenagon Asset Management S.A. Sells 42,752 Shares of Vulcan Materials Company $VMC

Assenagon Asset Management S.A. reduced its stake in Vulcan Materials Company (NYSE:VMC) by 19.7% in the second quarter, selling 42,752 shares. This leaves the institutional investor with 174,771 shares valued at $51,559,000. Other institutional investors have both increased and decreased their positions in VMC, …

Enterprise value to EBITDA forward of ENvue Medical, Inc. – NASDAQ:FEED

This article focuses on the enterprise value to EBITDA forward for ENvue Medical, Inc. (NASDAQ: FEED). It appears to be a financial data point presented within a TradingView context, indicating financial analysis for the company. The content primarily highlights the metric within the platform, …

Pacer Advisors Inc. Sells 3,705 Shares of Vulcan Materials Company $VMC

Pacer Advisors Inc. reduced its stake in Vulcan Materials Company (NYSE:VMC) by 34.2% in the first quarter, selling 3,705 shares and retaining 7,125 shares worth $1.94 million. Vulcan Materials exceeded earnings expectations, reporting $2.59 EPS on $2.16 billion revenue, and declared a quarterly dividend …

Wall Street Zen Downgrades Kenvue (NYSE:KVUE) to Hold

Wall Street Zen has downgraded Kenvue (NYSE:KVUE) from a "Buy" to a "Hold" rating, reflecting a consensus among analysts. The company's second-quarter revenue grew 3% year-over-year to $3.96 billion, but EPS and revenue slightly missed expectations due to inflationary pressures, tariffs, and currency costs. …

Kenvue Inc. $KVUE Shares Sold by Assenagon Asset Management S.A.

Assenagon Asset Management S.A. significantly reduced its stake in Kenvue Inc. (NYSE:KVUE) by 49.8% in the second quarter, selling 3.19 million shares and retaining 3.22 million shares. This move comes as Kenvue reported Q2 sales of $3.96 billion and adjusted EPS of $0.31, both …

Kenvue (KVUE) Stock Holds Firm As Margin Gains Anchor The Story

Cenovus Energy (NYSE:CVE) Raised to "Strong-Buy" at Wall Street Zen

Wall Street Zen has upgraded Cenovus Energy (NYSE:CVE) from a "buy" to a "strong-buy" rating. This upgrade comes as the company reported quarterly earnings in line with estimates and revenue that exceeded analyst expectations by 47.9% year-over-year. Despite the stock opening near its 52-week …

Corvus Pharmaceuticals (NASDAQ:CRVS) Posts Earnings Results, Misses Expectations By $0.03 EPS

Corvus Pharmaceuticals (NASDAQ:CRVS) reported a quarterly loss of $0.19 per share, missing analyst expectations by $0.03. Despite the earnings miss, the company extended its cash runway into Q2 2028 after a $189.4 million follow-on offering and reported encouraging Phase I results for soquelitinib in …

Noticias de acciones de Kenvue Inc (KVUE)

VMC (NYSE: VMC) insider David Clement plans Rule 144 sale of 2,000 shares

VMC insider David Clement has filed a Form 144 to sell 2,000 shares of common stock, valued at approximately $570,200.20, on August 7, 2026, through Morgan Stanley Smith Barney LLC. These shares are related to performance shares from December 31, 2025. Clement also reported …

Kenvue Inc (KVUE) Earnings Forecast: Future EPS & Revenue Growth Estimates

Kenvue (KVUE) reported Q2 earnings of $0.31 per share, missing the Zacks Consensus Estimate of $0.32, though it represents an increase from $0.29 per share a year ago. The company also missed revenue estimates, posting $3.96 billion against an expected $3.99 billion. Despite these …

Corvus Pharmaceuticals Loss Widens to $18 Million as Soquelitinib Trial Costs Soar

Corvus Pharmaceuticals reported a Q2 2026 net loss of $18 million, more than double the previous year, primarily due to increased R&D spending on its lead drug candidate, soquelitinib. Despite the wider loss, the company has a strong cash position of $215.2 million, projected …

Vulcan Materials Co. stock underperforms Friday when compared to competitors despite daily gains

Vulcan Materials Co. (VMC) stock gained 1.09% on Friday, closing at $284.69, amidst a positive trading day for the broader market with the S&P 500 and Dow Jones also rising. Despite its daily gains, the stock underperformed compared to competitors and remained 14.01% below …

Corvus Pharmaceuticals (NASDAQ:CRVS) Shares Gap Down After Earnings Miss

64-year-old luxury giant closes at least 217 stores, plans more

"Luxury goods are the only area in which it is possible to make luxury margins," said Bernard Arnault, CEO of LVMH, the world's largest luxury group behind powerhouses such as Louis Vuitton, Christian Dior, Fendi, and Givenchy. Arnault may be right about margins, but …